Analyst consensus rating
Inovio Pharmaceuticals Analyst Rating: none
Direct answer
Inovio Pharmaceuticals's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.17.
Forecast evidence checked September 16, 2026.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.16
- Average price target
- $3.17
- High price target
- $4.00
- Low price target
- $2.50
- Low target gap
- +115.5%
- Target upside
- +173%
- High target gap
- +244.8%
- Target range width
- 129.3%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 16, 2026
- Valid through
- September 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Inovio Pharmaceuticals?
Inovio Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $3.17.
How far are Inovio Pharmaceuticals's low and high targets from the recorded price?
The low target implies +115.5%, while the high target implies +244.8%.
How many analysts are included in Inovio Pharmaceuticals's consensus?
The verified consensus includes 3 analysts.
How is Inovio Pharmaceuticals's target upside or downside calculated?
The average target of $3.17 is divided by the recorded price of $1.16, then one is subtracted to produce +173%. This does not guarantee a future return.
When was Inovio Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-16. The dataset is valid through 2026-09-23.